Table 4 Proportions of adverse events by treatment group during follow-up
| Â | DHA/PQP (N = 199) | AL (N = 100) | p- Value |
|---|---|---|---|
Anorexia | 6.8% | 8.3% | 0.24 |
Cough | 21.2% | 15.4% | 0.04 |
Diarrhoea | 7.1% | 3.8% | 0.051 |
Fever | 12.0% | 14.4% | 0.32 |
Respiratory tract infections | 11.1% | 8.7% | 0.20 |
Vomiting | 2.6% | 3.8% | 0.29 |